| B33 | Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study) | Oral abstract session with live Q&A | ART in highly treatment-experienced people |
| B20 | Efficacy and safety of topical trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive patients (TECAIN): a randomized controlled trial | E-poster | Malignancies (AIDS and non-AIDS related) |
| A12 | Elevated levels of CCR5+ tissue resident CD4 T cells in female genital tract during follicular phase of HIV seronegative women | E-poster | Correlates of HIV susceptibility and disease progression (biomarkers and genetics) |
| C14 | Elucidating drivers for variations in the explosive HIV epidemics among people who inject drugs in Pakistan | E-poster | Modelling the HIV epidemic |
| B24 | Endocrine pathways of non-alcoholic fatty liver disease (NAFLD) in people living with HIV | E-poster | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |
| D21 | Enhanced early TB diagnosis through integrated sputum sample courier with HIV programs in six provinces in Zambia | E-poster | Integration of HIV services with TB programmes |
| C16 | Ensuring quality in HIV point of care testing for recent infections in a surveillance program | E-poster | Novel methods/algorithms for detecting acute and recent HIV infections |
| A41 | Epidemiological history of hepatitis B virus in Portugal and the Portuguese role in its spreading across the world | E-poster | Co-infection: Viral hepatitis |
| B12 | Epidemiological trends of hepatitis B morbidity and mortality in Greece, Italy, Portugal and Spain, 2000-2019: a systematic analysis from the Global Burden of Disease Study 2019 | E-poster | Viral hepatitis A, B, D and E |
| B4 | Establishment of a predictor risk score for the prioritization of patients for testing for Acute HIV Infection | E-poster | HIV testing and retesting |